Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesBeginning Cash BalanceBeginning Cash BalanceCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Summit Therapeutics (SMMT) Other financing activities (2018 - 2024)

Summit Therapeutics filings provide 7 years of Other financing activities readings, the most recent being $1.2 million for Q4 2024.

  • Quarterly Other financing activities changed N/A to $1.2 million in Q4 2024 from the year-ago period, while the trailing twelve-month figure was $1.2 million through Dec 2024, up 92.25% year-over-year, with the annual reading at $619000.0 for FY2023, 457.66% up from the prior year.
  • Other financing activities hit $1.2 million in Q4 2024 for Summit Therapeutics, up from $80000.0 in the prior quarter.
  • Across five years, Other financing activities topped out at $1.2 million in Q4 2024 and bottomed at -$41000.0 in Q4 2021.
  • Average Other financing activities over 5 years is $290285.7, with a median of $105000.0 recorded in 2021.
  • The largest annual shift saw Other financing activities surged 106.8% in 2020 before it crashed 185.42% in 2021.
  • Summit Therapeutics' Other financing activities stood at $48000.0 in 2020, then tumbled by 185.42% to -$41000.0 in 2021, then skyrocketed by 370.73% to $111000.0 in 2022, then decreased by 27.93% to $80000.0 in 2023, then skyrocketed by 1387.5% to $1.2 million in 2024.
  • Per Business Quant, the three most recent readings for SMMT's Other financing activities are $1.2 million (Q4 2024), $80000.0 (Q2 2023), and $539000.0 (Q1 2023).